Suppr超能文献

常用膳食补充剂与心血管药物的相互作用:系统评价。

Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review.

机构信息

Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa Hospital Research Institute, University of Ottawa Evidence-based Practice Center, Ottawa, ON, Canada.

出版信息

Syst Rev. 2012 May 31;1:26. doi: 10.1186/2046-4053-1-26.

Abstract

BACKGROUND

The objective of this systematic review was to examine the benefits, harms and pharmacokinetic interactions arising from the co-administration of commonly used dietary supplements with cardiovascular drugs. Many patients on cardiovascular drugs take dietary supplements for presumed benefits and may be at risk for adverse supplement-drug interactions.

METHODS

The Allied and Complementary Medicine Database, the Cochrane Library, EMBASE, International Bibliographic Information on Dietary Supplements and MEDLINE were searched from the inception of the review to October 2011. Grey literature was also reviewed.Two reviewers independently screened records to identify studies comparing a supplement plus cardiovascular drug(s) with the drug(s) alone. Reviewers extracted data using standardized forms, assessed the study risk of bias, graded the strength of evidence and reported applicability.

RESULTS

Evidence was obtained from 65 randomized clinical trials, 2 controlled clinical trials and 1 observational study. With only a few small studies available per supplement, evidence was insufficient for all predefined gradable clinical efficacy and harms outcomes, such as mortality and serious adverse events. One long-term pragmatic trial showed no benefit from co-administering vitamin E with aspirin on a composite cardiovascular outcome. Evidence for most intermediate outcomes was insufficient or of low strength, suggesting no effect. Incremental benefits were noted for triglyceridemia with omega-3 fatty acid added to statins; and there was an improvement in levels of high-density lipoprotein cholesterol with garlic supplementation when people also consumed nitrates

CONCLUSIONS

Evidence of low-strength indicates benefits of omega-3 fatty acids (plus statin, or calcium channel blockers and antiplatelets) and garlic (plus nitrates or warfarin) on triglycerides and HDL-C, respectively. Safety concerns, however, persist.

摘要

背景

本系统评价的目的是检验常用膳食补充剂与心血管药物联合使用所产生的益处、危害和药代动力学相互作用。许多心血管药物的使用者因认为补充剂有益而服用膳食补充剂,可能存在不良补充剂-药物相互作用的风险。

方法

从本评价开始至 2011 年 10 月,联合使用补充剂与心血管药物与单独使用药物的比较研究,在辅助和补充医学数据库、考科兰图书馆、EMBASE、国际补充剂文献数据库和 MEDLINE 中进行检索。还对灰色文献进行了综述。两位评审员独立筛选记录,以识别比较补充剂加心血管药物与单独使用药物的研究。评审员使用标准化表格提取数据,评估研究的偏倚风险,分级证据的强度,并报告适用性。

结果

从 65 项随机临床试验、2 项对照临床试验和 1 项观察性研究中获得了证据。由于每种补充剂只有少数小样本研究,因此对于所有预先确定的可分级临床疗效和危害结局,如死亡率和严重不良事件,证据都不足。一项长期的实用试验表明,维生素 E 与阿司匹林联合使用并不能改善复合心血管结局。对于大多数中间结局的证据不足或强度较低,提示没有效果。ω-3 脂肪酸与他汀类药物联合使用可降低甘油三酯;大蒜补充剂可改善同时服用硝酸盐的人群的高密度脂蛋白胆固醇水平

结论

低强度证据表明 ω-3 脂肪酸(加他汀类药物、钙通道阻滞剂和抗血小板药物)和大蒜(加硝酸盐或华法林)对甘油三酯和 HDL-C 分别有益。然而,安全性问题仍然存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59fd/3534595/4880f80e6912/2046-4053-1-26-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验